JPH0255433B2 - - Google Patents

Info

Publication number
JPH0255433B2
JPH0255433B2 JP59213786A JP21378684A JPH0255433B2 JP H0255433 B2 JPH0255433 B2 JP H0255433B2 JP 59213786 A JP59213786 A JP 59213786A JP 21378684 A JP21378684 A JP 21378684A JP H0255433 B2 JPH0255433 B2 JP H0255433B2
Authority
JP
Japan
Prior art keywords
group
dihydro
methyl
dimethyl
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59213786A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6191185A (ja
Inventor
Michihiro Yamamoto
Yukinori Ori
Nobuhiko Tamura
Akira Myagishi
Yoichi Hara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Priority to JP59213786A priority Critical patent/JPS6191185A/ja
Priority to US06/780,974 priority patent/US4705786A/en
Priority to CA000492042A priority patent/CA1326851C/en
Priority to ES85547724A priority patent/ES8704162A1/es
Priority to DE8585112872T priority patent/DE3576689D1/de
Priority to AT85112872T priority patent/ATE51229T1/de
Priority to EP85112872A priority patent/EP0177965B1/en
Priority to KR1019850007492A priority patent/KR920008819B1/ko
Publication of JPS6191185A publication Critical patent/JPS6191185A/ja
Priority to ES557234A priority patent/ES8900164A1/es
Publication of JPH0255433B2 publication Critical patent/JPH0255433B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
JP59213786A 1984-10-11 1984-10-11 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体 Granted JPS6191185A (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP59213786A JPS6191185A (ja) 1984-10-11 1984-10-11 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体
US06/780,974 US4705786A (en) 1984-10-11 1985-09-27 Novel oxadiazolyl-1,4-dihydropyridines useful as antihypertensive agents
CA000492042A CA1326851C (en) 1984-10-11 1985-10-02 Oxadiazolyl-1,4-dihydropyridines and the analogues thereof
ES85547724A ES8704162A1 (es) 1984-10-11 1985-10-09 Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos
AT85112872T ATE51229T1 (de) 1984-10-11 1985-10-10 Oxa- und thiadiazolylderivate und ihre verwendung.
DE8585112872T DE3576689D1 (de) 1984-10-11 1985-10-10 Oxa- und thiadiazolylderivate und ihre verwendung.
EP85112872A EP0177965B1 (en) 1984-10-11 1985-10-10 Novel oxa- and thiadiazolyl derivatives and their use
KR1019850007492A KR920008819B1 (ko) 1984-10-11 1985-10-11 옥사디아졸릴-1,4-디히드로피리딘 유도체 및 그의 산부가염의 제조방법
ES557234A ES8900164A1 (es) 1984-10-11 1986-12-01 Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59213786A JPS6191185A (ja) 1984-10-11 1984-10-11 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体

Publications (2)

Publication Number Publication Date
JPS6191185A JPS6191185A (ja) 1986-05-09
JPH0255433B2 true JPH0255433B2 (enExample) 1990-11-27

Family

ID=16645021

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59213786A Granted JPS6191185A (ja) 1984-10-11 1984-10-11 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体

Country Status (8)

Country Link
US (1) US4705786A (enExample)
EP (1) EP0177965B1 (enExample)
JP (1) JPS6191185A (enExample)
KR (1) KR920008819B1 (enExample)
AT (1) ATE51229T1 (enExample)
CA (1) CA1326851C (enExample)
DE (1) DE3576689D1 (enExample)
ES (2) ES8704162A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
GB8830226D0 (en) * 1988-12-23 1989-02-22 Beecham Group Plc Novel compounds
US5276150A (en) * 1989-05-31 1994-01-04 Fujirebio Inc. 1,4-dihydropyridine derivatives
US5670526A (en) * 1995-12-21 1997-09-23 Otsuka Pharmaceutical Co., Ltd. 1,3,4-oxadiazoles
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
DE102006044696A1 (de) 2006-09-22 2008-03-27 Bayer Healthcare Ag 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
ES557234A0 (es) 1989-03-01
US4705786A (en) 1987-11-10
CA1326851C (en) 1994-02-08
KR860003244A (ko) 1986-05-21
ES8900164A1 (es) 1989-03-01
EP0177965A3 (en) 1987-08-19
JPS6191185A (ja) 1986-05-09
ATE51229T1 (de) 1990-04-15
KR920008819B1 (ko) 1992-10-09
ES8704162A1 (es) 1987-03-16
ES547724A0 (es) 1987-03-16
EP0177965B1 (en) 1990-03-21
DE3576689D1 (de) 1990-04-26
EP0177965A2 (en) 1986-04-16

Similar Documents

Publication Publication Date Title
KR880002357B1 (ko) 디히드로피리딘 유도체의 제조방법
US4952689A (en) 3-(substituted propylidene)-2-azetidinone derivates for blood platelet aggregation
CA2178413A1 (en) Dihydropyridine npy antagonists: piperazine derivatives
EP0529702B1 (en) Dihydropyridine derivatives, their preparation and their use
JPH0912572A (ja) 窒素ヘテロ環誘導体であるジヒドロピリジンｎｐｙ拮抗剤
US4675321A (en) Substituted pyrimidines useful as calcium channel blockers
JPH05271078A (ja) ジヒドロピリジン類
KR920005742B1 (ko) 약제학상 유용한 디하이드로피리디닐디카르복실레이트 아마이드 및 에스테르의 제조방법
CS228506B2 (en) Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid
HK1005727B (en) Dihydropyridine derivatives, their preparation and their use
JPH0225913B2 (enExample)
JPS6172751A (ja) カルボニル化合物、その製造方法及び該化合物を含む医薬製剤
EP0255710A2 (en) 1,4-Dihydropyridine derivatives with calcium agonist and alpha-1-antagonist activity
PL140526B1 (en) Process for preparing novel substituted 1,4-dihydropyridines
JPH0255433B2 (enExample)
JPS6026106B2 (ja) アミノアルキリデンアミノ−１，４−ジヒドロピリジン及びその製造法
JPS61257983A (ja) １，４−ジヒドロピリジン及びこれを有効成分とする医薬組成物
JPH0629244B2 (ja) １，４−ジヒドロピリジン誘導体
JPH036151B2 (enExample)
HU204786B (en) Process for producing new dihydropyridine amide derivatives and pharmaceutical compositions comprising such compounds
US5064839A (en) 1,4-dihydropyridines with a 2-amino group or with an ether group in a side chain
CA1323876C (en) Dihydropyridine derivatives and pharmaceutical composition thereof
JP2664941B2 (ja) １，４―ジヒドロピリジン化合物
EP0370821B1 (en) 1,4-dihydropyridine derivatives
US6339083B1 (en) Multiheterocyclic pharmAceuticals